Xtl Biopharmaceuticals (XTLB) Research & Development (2011 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded Research & Development of -$28,000 in the year ended Dec 31, 2025, compared with -$16,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Research & Development (2011 - 2024) Analysis & Trends
Starting with the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Research & Development history includes 17 years.
- Annual Research & Development has ranged from -$31,000 in the year ended Dec 31, 2023 to -$16,000 in the year ended Dec 31, 2024 over the past five years.
- Per Business Quant data, XTLB's Research & Development was -$16,000 in the year ended Dec 31, 2024, -$31,000 in the year ended Dec 31, 2023, -$30,000 in the year ended Dec 31, 2022 and -$30,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.62 Bn | 1,127.21 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.97 Bn | 543.50 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.76 Bn | 483.88 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.50 Bn | 319.88 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 296.82 Bn | 260.81 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.02 Bn | 234.71 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 234.79 Bn | 190.19 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.67 Bn | 167.87 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.49 Bn | 118.14 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 82,000.00 |
| Sep 30, 2024 | -54,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | -45,000.00 |
| Jun 30, 2022 | 15,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | -42,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | -12,000.00 |
| Dec 31, 2020 | 64,000.00 |
| Sep 30, 2020 | -40,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Mar 31, 2020 | -3,000.00 |
API Access
Xtl Biopharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();